-+ 0.00%
-+ 0.00%
-+ 0.00%

Prestige Biologics CEO Lim Young Soo Raises Stake to 0.20% From 0.03%

PUBT·11/09/2026 01:06:45
Listen to the news
Prestige Biologics CEO Lim Young Soo Raises Stake to 0.20% From 0.03%
  • Prestige Biologics CEO Lim Young Soo increased his stake to 0.2% from 0.03% as of November 9, 2026.
  • Purchases of 137,500 common shares between November 4 and 9 raised his holdings to 155,949 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prestige Biologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261109000029), on November 09, 2026, and is solely responsible for the information contained therein.